Автор |
Akiba, Tadashi |
Автор |
Saijo, Nagahiro |
Автор |
Miyamoto, Kengo |
Автор |
Sakurai, Masanori |
Автор |
Tamura, Tomohide |
Автор |
Sasaki, Yasutsuna |
Автор |
Eguchi, Kenji |
Автор |
Shinkai, Tetsu |
Автор |
Uei, Yoshio |
Автор |
Fujiwara, Yasuhiro |
Автор |
Nakano, Hidehiko |
Автор |
Nakagawa, Kazuhiko |
Автор |
Hong, Weon Seon |
Дата выпуска |
1987 |
dc.description |
A 63-year-old man was admitted to the National Cancer Center Hospital on December 20, 1983 for a close examination of the abnormal shadows found in chest roentgenograms. Chest radiographs showed a massive right pleural effusion, a large tumor in the right bilar region and swelling of the left hilar nodes. Transcutaneous needle biopsy revealed the tumor's cytological type to be adenocarcinoma. The clinical stage was considered to be T3N2M1 (American joint committee (AJC) stage III M1), and his performance status was 4, so he was given etoposide (VP-16) alone as the initial chemotherapy treatment. He showed a partial response upon two courses of VP-16 therapy. Subsequently, one course of cisplatin (80 mg/m<sup>2</sup>) + vindesine (3.3 mg/m<sup>2</sup>), two courses of VP-16 (80 mg/m<sup>2</sup> D1–4), five courses of cyclophosphamide (80 mg/m<sup>2</sup>) + adriamycin (50 mg/m<sup>2</sup>) + vincristine (1.4 mg/m<sup>2</sup>) and two courses of VP-16 (100 mg/m<sup>2</sup> D1, 3, 5) were administered sequentially until May 31, 1985. No radiation therapy was given and, up to March 31, 1987, no sign of recurrence had been observed. |
Формат |
application.pdf |
Издатель |
Oxford University Press |
Копирайт |
© Oxford University Press |
Тема |
VP-16 |
Тема |
Non-small cell lung cancer |
Тема |
Case Reports |
Название |
A Case of Adenocarcinoma of the Lung which Was Successfully Treated by Chemotherapy with Patient Survival without Recurrence for More Than Three Years |
Тип |
case-report |
Electronic ISSN |
1465-3621 |
Print ISSN |
0368-2811 |
Журнал |
Japanese Journal of Clinical Oncology |
Том |
17 |
Первая страница |
165 |
Последняя страница |
172 |
Аффилиация |
Akiba Tadashi; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Saijo Nagahiro; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Miyamoto Kengo; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Sakurai Masanori; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Tamura Tomohide; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Sasaki Yasutsuna; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Eguchi Kenji; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Shinkai Tetsu; Department of Internal Medicine, National Cancer Center Hospital |
Аффилиация |
Uei Yoshio; Clinical Laboratory, National Cancer Center Hospital |
Аффилиация |
Fujiwara Yasuhiro; Pharmacology Division, National Cancer Center Research Institute |
Аффилиация |
Nakano Hidehiko; Pharmacology Division, National Cancer Center Research Institute |
Аффилиация |
Nakagawa Kazuhiko; Pharmacology Division, National Cancer Center Research Institute |
Аффилиация |
Hong Weon Seon; Pharmacology Division, National Cancer Center Research Institute |
Выпуск |
2 |